AbbVie
ABBV
#25
Rank
HK$3.158 T
Marketcap
HK$1,787
Share price
0.04%
Change (1 day)
34.25%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025HK$71.31 M-63.85%
2024HK$0.19 B-13.93%
2023HK$0.22 B-63.52%
2022HK$0.62 B629.28%
2021HK$86.13 M-77.97%
2020HK$0.39 B85.64%
2019HK$0.21 B-52.97%
2018HK$0.44 B269.88%
2017HK$0.12 B-48.45%
2016HK$0.23 B-37.53%
2015HK$0.37 B-44.13%
2014HK$0.67 B2387.79%
2013HK$27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
HK$29.26 MHK$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$5.67 MHK$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$0.29 BHK$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$21.81 MHK$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$36.76 MHK$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$2.15 MHK$78.49 M๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$61.56 MHK$0.39 B๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
HK$28.29 MHK$0.10 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$2.78 MHK$30.57 M๐Ÿ‡บ๐Ÿ‡ธ USA